Payment Systems

On May 18, 2026, the Centers for Medicare and Medicaid Services (CMS) published the final Notice of Benefit and Payment Parameters for 2027 (NBPP). The NBPP updates Affordable Care Act (ACA) marketplace standards and payment parameters for plan year 2027, qualified health plan (QHP) standards, risk adjustment, enrollment policies, Basic Health Program (BHP) policies, and implementation of provisions from the One Big Beautiful Bill legislation (Pub. L. 119-21).

On February 21, 2025, the Centers for Medicare & Medicaid Services (CMS) announced public engagement events for the second cycle of the Medicare Drug Price Negotiation Program.

On February 20, 2025, the Department of Health and Human Services (HHS) Office for Civil Rights (OCR) rescinded prior guidance on gender-affirming care, entitled “HHS Notice and Guidance on Gender Affirming Care, Civil Rights, and Patient Privacy,” issued March 2, 2022 (2022 Guidance).

On January 17, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the list of 15 additional Part D drugs for the Medicare Drug Price Negotiation Program.

In January 2025, the U.S. Department of Health and Human Services (HHS) issued a Strategic Plan for the Use of Artificial Intelligence in Health, Human Services, and Public Health in efforts to use AI responsibly to improve people's lives.

On December 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued explanations for the maximum fair prices (MFPs) for the drugs selected for the IRA’s Medicare Drug Price Negotiation Program for the initial price applicability year (IPAY) 2026.

On November 15, 2024, the Centers for Medicare & Medicaid Services (CMS) issued an update to the set of frequently asked questions (FAQs) related to the Medicare Prescription Payment Plan originally issued on October 1, 2024.

Video proceedings from the Partnership Forum "Addressing Evidence Gaps in the Expedited Programs Payer Perspectives."